Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cefrous I.5 Injection:
Cefrous I.5 Injection is a potent antibiotic formulation that combines Cefoperazone, a third-generation cephalosporin, with Sulbactam, a beta-lactamase inhibitor. This combination provides enhanced antibacterial activity, making it an effective choice for treating various bacterial infections.
Uses of Cefrous I.5 Injection:
Cefrous I.5 Injection is used in the treatment of:
Severe Bacterial Infections: Effective against a broad range of infections including respiratory tract infections, urinary tract infections, intra-abdominal infections, and skin and soft tissue infections.
Hospital-Acquired Infections: Provides effective treatment for infections acquired in a hospital setting, particularly those caused by beta-lactamase producing bacteria.
Benefits of Cefrous I.5 Injection:
Cefrous I.5 Injection offers significant benefits by combining the antibacterial efficacy of Cefoperazone with the beta-lactamase inhibiting action of Sulbactam. This dual-action approach enhances the effectiveness of the antibiotic therapy, ensuring comprehensive treatment of severe and resistant bacterial infections.
Mechanism of Action of Cefrous I.5 Injection:
Cefoperazone: A broad-spectrum cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death. It is effective against a wide variety of Gram-positive and Gram-negative bacteria.
Sulbactam: A beta-lactamase inhibitor that prevents the breakdown of beta-lactam antibiotics by beta-lactamase enzymes, thereby enhancing the efficacy of Cefoperazone against resistant bacteria.
Consult your healthcare provider to determine if Cefrous I.5 Injection is the appropriate treatment for managing your bacterial infection.